Vaccination of cattle against bovine viral diarrhoea

Veterinary Microbiology

Volumn 64, Issue 2-3, 1999, Pages 169-183

  Oirschot, J T Van ^a   Bruschke, C J M ^a   Rijn, P A Van ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Antigenic diversity; Bovine virus diarrhoea; Congenital infection; Vaccine efficacy; Vaccine safety

Indexed keywords

INACTIVATED VACCINE; LIVE VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANTIGENICITY; BACULOVIRUS; BOVINE DIARRHEA VIRUS; BOVINE HERPES VIRUS; CATTLE DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONGENITAL INFECTION; DRUG SAFETY; HAEMOPHILUS; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; META ANALYSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PARAINFLUENZA VIRUS 3; PASTEURELLA; POSTNATAL CARE; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUSES, BOVINE VIRAL; DISEASE RESERVOIRS; FETUS; VACCINATION; VACCINES, ATTENUATED; VACCINES, COMBINED; VACCINES, INACTIVATED; VIRAL VACCINES;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1; HAEMOPHILUS; HERPES; HERPESVIRIDAE; HUMAN PARAINFLUENZA VIRUS 3; PASTEURELLA; RESPIRATORY SYNCYTIAL VIRUS; RNA VIRUSES; UNIDENTIFIED BACULOVIRUS;

EID: 0033004715     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(98)00268-5     Document Type: Conference Paper

References (73)

1. Anderson J., Mertens P.P.C., Herniman K.A.J. A competitive ELISA for the detection of anti-tubule antibodies using a monoclonal antibody against Bluetongue virus non-structural protein NS1. J. Virol. Meth. 43:1993;167-176.
2. Baker J.A., York C.J., Gillespie J.H., Michell G.B. Viral diarrhea in cattle. Vet. Res. 15:1954;525-531.
3. Becher P., Orlich M., Shannon A.D., Horner G., König M., Thiel H.-J. Phylogenetic analysis of pestiviruses from domestic and wild ruminants. J. Gen. Virol. 78:1997;1357-1366.
4. Birch-Machin I., Rowan A., Pick J., Mumford J., Binns M. Expression of the non-structural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera. J. Virol. Meth. 65:1997;255-263.
5. Bolin S.R. Immunogens of bovine viral diarrhea virus. Vet. Microb. 37:1993;263-271.
6. Bolin, S.R., McClurkin, A.W., Cutlip, R.C., Coria M.F., 1985a. Severe clinical disease induced in cattle persistently infected with noncytopathic bovine viral diarrhea virus by superinfection with cytopathic bovine viral diarrhea virus. Am. J. Vet. Res. 46, 573-576.
7. Bolin, S.R., McClurkin, A.W., Cutlip, R.C., Coria M.F., 1985b. Response of cattle persistently infected with noncytopathic bovine viral diarrhea virus to vaccination for bovine viral diarrhea and to subsequent challenge exposure with cytopathic bovine viral diarrhea virus. Am. J. Vet. Res. 46, 2467-2470.
8. Bolin S.R., Ridpath J.F. Specificity of neutralizing and precipitating antibodies induced in healthy calves by monovalent modified-live bovine viral diarrhea virus vaccines. Am. J. Vet. Res. 50:1989;817-821.
9. Bolin S.R., Ridpath J.F. Range of viral neutralizing activity and molecular specifity of antibodies induced in cattle by inactivated bovine viral diarrhea virus vaccines. Am. J. Vet. Res. 51:1990;703-707.
10. Bolin S.R., Ridpath J.F. Glycoprotein E2 of bovine viral dairrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease. Arch. Virol. 141:1996;1463-1477.
11. Brock, K.V., Grooms, D.L., 1996. Evaluation of a modified-live bovine viral diarrhoea virus vaccine by fetal challenge. Proc. 3rd ESVV Symp. Pestivirus Infections, September 19-20, Lelystad, The Netherlands, pp. 177-179. Publ. CVL, Weybridge, UK.
12. Brownlie J., Clarke M.C., Howard C.J. Experimental production of fatal mucosal disease in cattle. Vet. Rec. 114:1984;535-536.
13. Brownlie J., Clarke M.C., Hooper L.B., Bell G.D. Protection of bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet. Rec. 137:1995;58-62.
14. Bruschke C.J.M., Van Rijn P.A., Moormann R.J.M., Van Oirschot J.T. Antigenically different pestivirus strains induce congenital infection in sheep: a model for bovine virus diarrhea virus vaccine efficacy studies. Vet. Microb. 50:1996;33-43.
15. Bruschke, C.J.M., Moormann, R.J.M., Van Oirschot, J.T., Van Rijn, P.A., 1997. A sub-unit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine, in press.
16. Bruschke, C.J.M., Van Oirschot, J.T., Van Rijn, P.A., 1998. Two conventional inactivated BVDV vaccines do not prevent congenital infection, in preparation.
17. Carlsson U., Alenius S., Sundquist B. Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes. Vaccine. 9:1991;577-580.
18. Chennekatu P.P., Tyler D.E., Ramsey F.K. Characteristics of a condition following vaccination with bovine virus diarrhea vaccine. JAVMA. 150:1967;46-52.
19. Childs T. Disease of cattle. Saskatchewan. Can. J. comp. Med. 10:1946;316-319.
20. Coggins L., Gillespie J.H., Robson D.S., Thompson J.D., Phillips W.V., Wagner W.C., Baker J.A. Attenuation of virus diarrhea virus (strain oregon C24V) for vaccine purposes. Cornell Vet. 51:1961;539-545.
21. Corapi W.V., French T.W., Dubovi E.J. Severe thrombocytopenia in young calves experimentally infected with noncytopathic bovine viral diarrhea virus. J. Virol. 63:1989;3934-3943.
22. Cortese, V.S., West, K., Ellis, J., 1996. Clinical and immunologic responses to type 2 BVDV challenge in vaccinated and unvaccinated calves. BCVA Edinburgh, pp. 610-613.
23. De Jong M.C.M., Kimman T.G. Experimental quantification of vaccine-induced reduction in virus transmission. Vaccine. 12:1994;761-766.
24. Donis, R.O., Krejci, A., 1992. Fatal iatrogenic mucosal disease caused by modified live bovine viral diarrhea virus. Proc. 2nd Symp. Pestiviruses, Veyrier-du-Lac, October 1-3, pp. 149-155.
25. Duffell S.J., Sharp M.W., Winkler C.E., Terlecki S., Richardson C., Done J.T., Roeder P.L., Hebert C.N. Bovine virus diarrhoea-mucosal disease virus-induced fetopathy in cattle: efficacy of prophylactic maternal pre-exposure. Vet. Rec. 114:1984;558-561.
26. Fuller D.A. When to vaccinate for IBR-VD. Mod. Vet. Prac. 46:1965;40-43.
27. Gratzek J.B., Segre D., Berman D.T. Detection and isolation of a virus contaminating a stock of virus diarrhea virus. Am. J. Vet. Res. 25:1964;374-379.
28. Gutekunst D.E., Malmquist W.A. Complement-fixing and neutralizing antibody response to bovine viral diarrhea and hog cholera antigens. Can. J. of Comp. Med. 28:1964;19-23.
29. Hafez S.M., Liess B., Frey H.-R. Studies on the natural occurrence of neutralizing antibodies against six strains of bovine viral diarrhea virus in field sera of cattle. Zbl. Vet. Med. B. 23:1976;669-677.
30. Harkness, J.W., Roeder, P.L., Drew, T., Wood, L., Jeffrey, M., 1985. In: Harkness, J.W. (Ed.), The efficacy of an experimental inactivated BVD-MD vaccine. Proc. CEC seminar on research on animal husbandry, September 10-11, pp. 233-250.
31. Harpin S., Talbot B., Mbikay M., Elazhary Y. Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2). FEMS Microb. Lett. 146:1997;229-234.
32. Howard C.J., Clarke M.C., Brownlie J. Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody. Vet. Microb. 19:1989;195-203.
33. Howard C.J., Clarke M.C., Sopp P., Brownlie J. Systemic vaccination with inactivated bovine virus diarrhoea virus protects against respiratory challenge. Vet. Microb. 42:1994;171-179.
34. Hulst M.M., Westra D.F., Wensvoort G., Moormann R.J.M. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Virol. 67:1993;5435-5442.
35. Kaashoek M.J., Moerman A., Madić J.A., Weerdmeester K., Maris-Veldhuis M.A., Rijsewijk F.A.M., Van Oirschot J.T. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine. 13:1995;342-346.
36. Kelling C.L., Kennedy J.E., Rump K.K., Stine L.C., Paul P.S., Partridge J.E. Monitoring bovine viral diarrhea virus vaccines for adventitous virus, using T1 ribonuclease viral RNA oligonucleotide fingerprinting. Am. J. Vet. Res. 52:1991;1237-1244.
37. King A.A., Harkness J.W. Viral contamination of foetal bovine serum. Vet. Rec. 97:1975;16.
38. Kramps, J.A., van Maanen, C., van de Wetering, G., Stienstra, G., Quak, S., Brinkhof, J., Rønsholt, L., Nylin, B., 1999. A simple, rapid and reliable enzyme-linked immunosorbent assay for the detection of bovine virus diarrhoea virus (BVDV) specific antibodies in cattle serum, plasma and bulk milk. Vet. Microbiol. 64, 135-144.
39. Lecomte C., Pin J.J., DeMoerlooze L., Vandenbergh D., Lambert A.F., Pastoret P.P., Chappuis G. ELISA detection of bovine viral diarrhoea virus specific antibodies using recombinant antigen and monoclonal antibodies. Vet. Microb. 23:1990;193-201.
40. Liess B., Orban S., Frey H.-R., Trautwein G., Wiefel W., Blindow H. Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus in cattle. Zbl. Vet. Med. B. 31:1984;669-681.
41. Lobmann M.S., Charlier P., Florent G., Zygraich N. Clinical evaluation of a temperature-sensitive bovine viral diarrhea vaccine strain. Am. J. Vet. Res. 45:1984;2498-2503.
42. Lubroth J., Grubman M.J., Burrage T.G., Newman J.F.E., Brown F. Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals. Vaccine. 14:1996;419-427.
43. Martin S.W. Vaccination: is it effective in preventing respiratory disease or influencing weight gains in feedlot calves. Can. Vet. J. 24:1983;10-19.
44. McClurkin A.W., Coria M.F., Smith R.L. Evaluation of acetylethyleneimine-killed bovine viral diarrhea-mucosal disease virus (BVD) vaccine for prevention of BVD infection of the fetus. Proc. U.S. Anim. Hlth. Assoc. 79:1975;114-123.
45. Meyers G., Tautz N., Becher P., Thiel H.-J., Kümmerer B.M. Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs. J. Virol. 70:1996;8606-8613.
46. Meyling, A., Ronsholt, L., Dalsgaard, K., Jensen, A.M., 1987. In: Harkness, J.W. (Ed.), Experimental exposure of vaccinated and non-vaccinated pregnant cattle to isolates of bovine viral diarrhoea virus (BVDV). Proc. CEC seminar on research on animal husbandry, September 10-11, 1985, pp. 225-231.
47. Moerman A., Straver P.J., De Jong M.C.M., Quak J., Baanvinger Th., Van Oirschot J.T. A long term epidemiological study of bovine viral diarrhoea infections in a large herd of dairy cattle. Vet. Rec. 132:1993;622-626.
48. Nuttall P.A., Luther P.D., Stott E.J. Viral contamination of bovine foetal serum and cell cultures. Nature. 266:1977;835-837.
49. Olafson P., MacCallum A.D., Fox F.H. An apparently new transmissible disease of cattle. Corn. Vet. 36:1946;205-213.
50. Orban S., Liess B., Hafez S.M., Frey H.-R., Blindow H., Sasse-Patzer B. Studies on transplancental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus. Zbl. Vet. Med. B. 30:1983;619-634.
51. Paton D.J., Ibata G., Edwards S., Wensvoort G. An ELISA detecting antibody to conserved pestivirus epitopes. J. Virol. Meth. 31:1991;315-324.
52. Paton D.J. Pestivirus diversity. J. Comp. Path. 112:1995;215-236.
53. Pellerin C., Van den Hurk J., Lecomte J., Tijssen P. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and hig mortalities. Virology. 203:1994;260-268.
54. Perino L.J., Hunsaker B.D. A review of bovine respiratory disease vaccine field efficacy. Bovine Pract. 31:1997;59-66.
55. Phillips R.M., Heuschele W.P., Todd J.D. Evaluation of a bovine viral diarrhea vaccine produced in a porcine kidney cell line. Am. J. Vet. Res. 36:1975;135-140.
56. Pritchard, W.R., Carlson, R.G., Moses, H.E., Taylor, D.E.B., 1955. Virus diarrhea and mucosal disease. Prog. 59th Ann. Meet. U.S. Livestock Sanit. Assoc., pp. 173-188.
57. Rebhun W.C., French T.W., Perdrizet J.A., Dubovi E.J., Dill S.G., Karcher L.F. Thrombocytopenia associated with acute bovine virus diarrhea infection in cattle. J. Vet. Intern. Med. 3:1989;42-46.
58. Reddy D.N., Reddy P.G., Xue W., Minocha H.C., Daley M.J., Blecha F. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 β and interleukin-2. Vet. Immunol. Immunopath. 37:1993;25-38.
59. Ridpath J.F., Bolin S.R., Dubovi E.J. Segregation of bovine viral diarrhea virus into genotypes. Virology. 205:1994;66-74.
60. Roth J.A., Kaeberle M.L. Suppression of neutrophil and lymphocyte function induced by a vaccinal strain of bovine viral diarrhea virus with and without administration of ACTH. Am. J. Vet. Res. 44:1983;2366-2372.
61. Rümenapf T., Stark R., Meyers G., Thiel H.-J. Structural proteins of hog cholera virus expressed by vaccinia virus. Further characterization and induction of protective immunity. J. Virol. 65:1991;589-597.
62. Smedegaard Madsen E., Madsen K.G., Nielsen J., Holm Jensen M., Lei J.C., Have P. Detection of antibodies against porcine parvovirus nonstructural protein NS1 may distinguish between vaccinated and infected pigs. Vet. Microb. 54:1997;1-16.
63. Talens L.T., Beckenhauer W.H., Thurber E.T., Cooley A.J., Schultz R.D. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle. JAVMA. 194:1989;1273-1280.
64. Tamoglia T.W. Laboratory evaluation of bovine respiratory disease vaccines for safety. JAVMA. 152:1968;847-850.
65. Terpstra, C., Eikelenboom, J.L., Glas, C., 1982. Experience with early vaccination of fattening calves against infectious bovine rhinotracheitis, bovine virus diarrhoea and parainfluenza type 3. Proc. XIIth Buiatrics Congress, Amsterdam, pp. 177-181.
66. Thoen C.O., Waite K.J. Some immune responses in cattle exposed to Myco-bacterium paratuberculosis after injection with modified-live bovine viral diarrhea virus vaccine. J. Vet. Diagn. Invest. 2:1990;176-179.
67. Underdahl N.R., Grace O.D., Hoerlein A.B. Cultivation in tissue-culture of cytopathogenic agent from bovine mucosal disease. Proc. Soc. Exp. Bio. Med. 94:1957;795-797.
68. Van Oirschot J.T., Rziha H.J., Moonen P.J.L.M., Pol J.M.A., Van Zaane D. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J. Gen. Virol. 67:1986;1179-1182.
69. Van Rijn, P.A., Van Gennip, H.G.P., Leendertse, C.H., Bruschke, C.J.M., Paton, D.J., Moormann, R.J.M., Van Oirschot, J.T., 1997. Subdivision of the Pestivirus genus based on envelope glycoprotein E2. Virology, in press.
70. Van Zijl M., Wensvoort G., De Kluyver E., Hulst M.M., Van der Gulden H., Gielkens A., Berns A., Moormann R.J.M. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J. Virol. 65:1991;2761-2765.
71. Vassilev V.B., Collett M.S., Donis R.O. Authentic and chimeric full-length genomic cDNA clones of bovine viral diarrhea virus that yield infectious transcripts. J. Virol. 71:1997;471-478.
72. Xu J., Mendez E., Caron P.R., Lin C., Murcko M.A., Collett M.S., Rice C.M. Bovine viral diarrhea virus NS3 serine protease: polyprotein cleavage sites, cofactor requirements, and molecular model of an enzyme essential for pestivirus replication. J. Virol. 71:1997;5312-5322.
73. Zimmer, G.M., Wentink, G.H., Brinkhof, J., Bruschke, C.J.M., Westenbrink, F., Crauwels, A.P.P., De Goey, I., 1996. Model for testing efficacy of bovine viral diarrhoea virus vaccines against intrauterine infection. In: Proc. XIX World Buiatrics Congr., Edinburgh, pp. 217-220.